Microsoft Word - MGCD Q4FY2015 CC Announcement FINAL_121715


MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874

Facsimile: (651) 484-4826


FOR IMMEDIATE RELEASE


MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2015 Financial Results on Wednesday, January 6, 2016 SAINT PAUL, MN (December 17, 2015) - MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2015, ended October 31, 2015. The call will be at 4:30 p.m. ET on Wednesday, January 6, 2016. The Company will report financial results for the fourth quarter and fiscal year 2015 after the markets close on Wednesday, January 6, 2016.


Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or listen via a live Internet webcast on the Company's website at www.mgcdiagnostics.com. A replay of the conference call will be available by dialing (877) 344-7529 or (412) 317-0088, confirmation code 10077496, through January 13, 2016. A webcast replay of the conference call will be accessible on the Company's website at www.mgcdiagnostics.com for 90 days.


About MGC Diagnostics


MGC Diagnostics Corporation (NASDAQ: MGCD), is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its Medical Graphics Corporation and MediSoft SA subsidiaries, develops, manufactures and markets non‐invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.


Contact: Wesley W. Winnekins Joe Dorame, Robert Blum, Joe Diaz MGC Diagnostics Corporation Lytham Partners, LLC

Chief Financial Officer (602) 889-9700

(651) 484-4874 mgcd@lythampartners.com

MGC Diagnostics Corporation issued this content on 2015-12-17 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-17 20:44:04 UTC

Original Document: http://mgcdiagnostics.com/images/uploads/MGCD_Q4FY2015_CC_Announcement__121715.pdf